Rhythm Pharmaceuticals Inc (RYTM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Sales | 274 | 35 | 0 | 0 | 0 |
| Cost of Goods | 137 | 4 | N/A | N/A | N/A |
| Gross Profit | 137 | 31 | N/A | N/A | N/A |
| Operating Expenses | 40,706 | 34,433 | 35,073 | 34,284 | 31,918 |
| Operating Income | -40,432 | -34,398 | -35,073 | -34,284 | -31,918 |
| Other Income | 21 | 100,154 | 176 | 466 | 801 |
| Pre-tax Income | -40,411 | 65,756 | -34,897 | -33,818 | -31,117 |
| Income Tax | -5,022 | 22,006 | N/A | N/A | N/A |
| Net Income Continuous | -35,389 | 43,750 | -34,897 | -33,818 | -31,117 |
| Net Income | $-35,389 | $43,750 | $-34,897 | $-33,818 | $-31,117 |
| EPS Basic Total Ops | -0.70 | 0.92 | -0.78 | -0.77 | -0.71 |
| EPS Basic Continuous Ops | -0.70 | 0.92 | -0.79 | -0.77 | -0.71 |
| EPS Diluted Total Ops | -0.70 | 0.90 | -0.78 | -0.77 | -0.71 |
| EPS Diluted Continuous Ops | -0.70 | 0.90 | -0.79 | -0.77 | -0.71 |
| EBITDA(a) | $-40,115 | $-34,197 | $-34,895 | $-34,112 | $-31,745 |